NFKB1 and kidney disorder: Despite further extensive work that will be necessary to perfectly elucidate all possible off‐targets and mechanism of action elicited by these imidazolones, they represent a promising chemical tool for the study and modulation of the NF‐κB signaling in the context of kidney disease.